Bharat Biotech's intranasal Covid-19 vaccine approved for restricted use
It’s India's first nasal vaccine against Covid-19. Health minister Mansukh Mandaviya says it’ll further strengthen country's fight against pandemic
bharat biotech
September 2022
June 2022
May 2022
April 2022
March 2022
December 2021
November 2021
October 2021
COVAXIN shows safety, immunogenicity in children aged 2-18 years: Lancet
Peer-reviewed data has been published in Lancet Infectious Diseases; phase II-III study was held to evaluate safety, and immunogenicity of COVAXIN among healthy children and adolescents.
$19.3 million to Bharat Biotech consortium for ‘variant-proof’ Covid vaccine
The funding seeks to establish preclinical and clinical proof of concept for a vaccine designed to provide protection against all known SARS-CoV-2 variants.
Covaxin, Corbevax get 'emergency use' nod for kids aged 5-12
The CDSCO approval has also been granted for two doses of ZyCov-D for those aged over 12. The decision comes amid a rise in Covid cases in cities like Delhi.
Bharat Biotech's US partner to commercialise Covaxin in Mexico
In addition to the US and Canada, Ocugen will also have the exclusive rights for supply and commercialisation of Covaxin in Mexico.
Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine
Technology Development Board and Bharat Biotech will put in ₹200 crore each to create a continuous corpus of ₹400 crore for the partnership project.
Predictions 2022: India to consolidate in vaccine-making for the world, says Bharat Biotech's Krishna Ella
The advancement of science in the year to come will be influenced significantly by the government's academic policies, writes Bharat Biotech CMD Krishna Ella.
Be tough on people not disciplined: Bharat Biotech's Suchitra Ella
Ella was the company’s go-to person during the production of its indigenously developed Covid-19 vaccine, Covaxin—engaging with multiple ministries almost on a daily basis.
Next target for Covid vaccine: 200 crore; How soon?
100 crore shots and rising.
Eager for WHO approval for Covaxin: Suchitra Ella
As countries open their borders to travel, tourism and education, Bharat Biotech’s Covaxin awaits WHO’s nod on October 26. Co-founder, Suchitra Ella, is hopeful of a positive answer.
